SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041615
Filing Date
2023-08-11
Accepted
2023-08-11 08:10:44
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-20230630.htm   iXBRL 10-Q 2519761
2 EX-10.1 rapt-ex10_1.htm EX-10.1 64837
3 EX-31.1 rapt-ex31_1.htm EX-31.1 21780
4 EX-31.2 rapt-ex31_2.htm EX-31.2 21805
5 EX-32.1 rapt-ex32_1.htm EX-32.1 23911
  Complete submission text file 0000950170-23-041615.txt   7809347

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rapt-20230630_lab.xml EX-101.LAB 335690
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rapt-20230630_pre.xml EX-101.PRE 242637
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rapt-20230630_cal.xml EX-101.CAL 46550
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rapt-20230630_def.xml EX-101.DEF 141086
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rapt-20230630.xsd EX-101.SCH 40092
55 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20230630_htm.xml XML 1408946
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 231161612
SIC: 2834 Pharmaceutical Preparations